Andrew K Balo Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew K Balo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew K Balo. Andrew K Balo is * in DEXCOM INC ($DXCM) and EVP, Clinical and Regulatory in DEXCOM INC ($DXCM) and EVP, Clinical, Regulatory in DEXCOM INC ($DXCM) and EVP, Reg. Strategy, Clinical in DEXCOM INC ($DXCM) and VP of Clinical & Regulatory in DEXCOM INC ($DXCM).
Latest Insider Trading Transactions of Andrew K Balo
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 362.92 | 5,566 | 2,019,996 | 35,307 | 40.9 K to 35.3 K (-13.62 %) |
| Mar 10 2021 | DXCM | DEXCOM INC | Balo Andrew K | * | Grant | A | 0.00 | 5,301 | 5 | 40,873 | 35.6 K to 40.9 K (+14.90 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 397.35 | 5,256 | 2,088,490 | 35,567 | 40.8 K to 35.6 K (-12.88 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 397.35 | 5,256 | 2,088,490 | 35,567 | 40.8 K to 35.6 K (-12.88 %) |
| Sep 11 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 398.30 | 3,297 | 1,313,202 | 40,823 | 44.1 K to 40.8 K (-7.47 %) |
| Sep 11 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 398.30 | 1,283 | 511,021 | 44,120 | 45.4 K to 44.1 K (-2.83 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 370.39 | 250 | 92,599 | 45,376 | 45.6 K to 45.4 K (-0.55 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 370.05 | 2,239 | 828,533 | 45,626 | 47.9 K to 45.6 K (-4.68 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 368.29 | 300 | 110,488 | 47,865 | 48.2 K to 47.9 K (-0.62 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 367.18 | 250 | 91,796 | 48,165 | 48.4 K to 48.2 K (-0.52 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 366.62 | 400 | 146,649 | 48,415 | 48.8 K to 48.4 K (-0.82 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 365.03 | 1,402 | 511,772 | 48,815 | 50.2 K to 48.8 K (-2.79 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 363.46 | 205 | 74,510 | 50,217 | 50.4 K to 50.2 K (-0.41 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 362.72 | 776 | 281,469 | 50,422 | 51.2 K to 50.4 K (-1.52 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 361.45 | 200 | 72,290 | 51,198 | 51.4 K to 51.2 K (-0.39 %) |
| Jun 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 359.98 | 500 | 179,991 | 51,398 | 51.9 K to 51.4 K (-0.96 %) |
| Apr 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 287.75 | 51 | 14,675 | 51,898 | 51.9 K to 51.9 K (-0.10 %) |
| Apr 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 286.24 | 730 | 208,956 | 51,949 | 52.7 K to 51.9 K (-1.39 %) |
| Apr 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 285.14 | 2,385 | 680,065 | 52,679 | 55.1 K to 52.7 K (-4.33 %) |
| Apr 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 284.19 | 1,110 | 315,456 | 55,064 | 56.2 K to 55.1 K (-1.98 %) |
| Apr 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 281.10 | 1,382 | 388,477 | 56,174 | 57.6 K to 56.2 K (-2.40 %) |
| Apr 17 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 279.33 | 1,032 | 288,266 | 57,556 | 58.6 K to 57.6 K (-1.76 %) |
| Mar 13 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 265.43 | 7,840 | 2,080,940 | 58,588 | 66.4 K to 58.6 K (-11.80 %) |
| Mar 13 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 250.15 | 319 | 79,799 | 66,428 | 66.7 K to 66.4 K (-0.48 %) |
| Mar 13 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 246.18 | 2 | 492 | 66,747 | 66.7 K to 66.7 K (0.00 %) |
| Mar 10 2020 | DXCM | DEXCOM INC | Balo Andrew K | * | Grant | A | 0.00 | 8,811 | 9 | 66,749 | 57.9 K to 66.7 K (+15.21 %) |
| Sep 19 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 151.46 | 2,386 | 361,384 | 57,916 | 60.3 K to 57.9 K (-3.96 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 159.92 | 244 | 39,021 | 60,302 | 60.5 K to 60.3 K (-0.40 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 159.92 | 244 | 39,021 | 60,302 | 60.5 K to 60.3 K (-0.40 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 158.42 | 269 | 42,615 | 60,546 | 60.8 K to 60.5 K (-0.44 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 158.42 | 269 | 42,615 | 60,546 | 60.8 K to 60.5 K (-0.44 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 157.78 | 450 | 70,999 | 60,815 | 61.3 K to 60.8 K (-0.73 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 157.78 | 450 | 70,999 | 60,815 | 61.3 K to 60.8 K (-0.73 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 156.43 | 550 | 86,039 | 61,265 | 61.8 K to 61.3 K (-0.89 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 156.43 | 550 | 86,039 | 61,265 | 61.8 K to 61.3 K (-0.89 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 155.36 | 100 | 15,536 | 61,815 | 61.9 K to 61.8 K (-0.16 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 155.36 | 100 | 15,536 | 61,815 | 61.9 K to 61.8 K (-0.16 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 154.00 | 40 | 6,160 | 61,915 | 62 K to 61.9 K (-0.06 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 154.00 | 40 | 6,160 | 61,915 | 62 K to 61.9 K (-0.06 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 152.59 | 600 | 91,554 | 61,955 | 62.6 K to 62 K (-0.96 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 152.59 | 600 | 91,554 | 61,955 | 62.6 K to 62 K (-0.96 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 151.49 | 621 | 94,077 | 62,555 | 63.2 K to 62.6 K (-0.98 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 151.49 | 621 | 94,077 | 62,555 | 63.2 K to 62.6 K (-0.98 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 150.52 | 279 | 41,996 | 63,176 | 63.5 K to 63.2 K (-0.44 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 150.52 | 279 | 41,996 | 63,176 | 63.5 K to 63.2 K (-0.44 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 150.11 | 5,629 | 844,975 | 63,455 | 69.1 K to 63.5 K (-8.15 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 150.11 | 5,629 | 844,975 | 63,455 | 69.1 K to 63.5 K (-8.15 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 145.43 | 325 | 47,264 | 69,084 | 69.4 K to 69.1 K (-0.47 %) |
| Sep 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 145.43 | 325 | 47,264 | 69,084 | 69.4 K to 69.1 K (-0.47 %) |
| Sep 05 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 170.00 | 37 | 6,290 | 69,409 | 69.4 K to 69.4 K (-0.05 %) |
| Jun 06 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 125.00 | 7,825 | 978,125 | 69,392 | 77.2 K to 69.4 K (-10.13 %) |
| Mar 13 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 142.79 | 2,296 | 327,851 | 77,217 | 79.5 K to 77.2 K (-2.89 %) |
| Mar 13 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 142.79 | 6,399 | 913,727 | 79,513 | 85.9 K to 79.5 K (-7.45 %) |
| Mar 13 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Sell | S | 142.79 | 2,222 | 317,284 | 85,912 | 88.1 K to 85.9 K (-2.52 %) |
| Mar 11 2019 | DXCM | DEXCOM INC | Balo Andrew K | * | Grant | A | 0.00 | 14,987 | 15 | 88,134 | 73.1 K to 88.1 K (+20.49 %) |
| Dec 18 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 121.38 | 4,373 | 530,782 | 73,105 | 77.5 K to 73.1 K (-5.64 %) |
| Dec 18 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 120.23 | 627 | 75,384 | 77,478 | 78.1 K to 77.5 K (-0.80 %) |
| Nov 16 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 144.43 | 1,498 | 216,359 | 78,105 | 79.6 K to 78.1 K (-1.88 %) |
| Nov 16 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 143.88 | 1,502 | 216,101 | 79,603 | 81.1 K to 79.6 K (-1.85 %) |
| Nov 16 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 142.13 | 800 | 113,704 | 81,105 | 81.9 K to 81.1 K (-0.98 %) |
| Nov 16 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 141.25 | 1,200 | 169,501 | 81,905 | 83.1 K to 81.9 K (-1.44 %) |
| Oct 16 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 125.24 | 2,009 | 251,598 | 83,105 | 85.1 K to 83.1 K (-2.36 %) |
| Oct 16 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 124.49 | 2,991 | 372,336 | 85,114 | 88.1 K to 85.1 K (-3.39 %) |
| Sep 18 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 145.27 | 4,400 | 639,174 | 88,105 | 92.5 K to 88.1 K (-4.76 %) |
| Sep 18 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 144.46 | 600 | 86,677 | 92,505 | 93.1 K to 92.5 K (-0.64 %) |
| Sep 12 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 143.76 | 3,180 | 457,142 | 93,105 | 96.3 K to 93.1 K (-3.30 %) |
| Sep 12 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 143.76 | 2,407 | 346,019 | 96,285 | 98.7 K to 96.3 K (-2.44 %) |
| Aug 16 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 124.96 | 550 | 68,727 | 98,567 | 99.1 K to 98.6 K (-0.55 %) |
| Aug 16 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 124.16 | 4,450 | 552,526 | 99,117 | 103.6 K to 99.1 K (-4.30 %) |
| Jul 18 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 100.73 | 500 | 50,365 | 103,567 | 104.1 K to 103.6 K (-0.48 %) |
| Jul 18 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 99.90 | 1,800 | 179,823 | 104,067 | 105.9 K to 104.1 K (-1.70 %) |
| Jul 18 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 99.12 | 2,700 | 267,628 | 105,867 | 108.6 K to 105.9 K (-2.49 %) |
| Mar 14 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | D | 60.73 | 4,464 | 271,101 | 108,567 | 113 K to 108.6 K (-3.95 %) |
| Mar 14 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | D | 60.73 | 2,221 | 134,883 | 113,031 | 115.3 K to 113 K (-1.93 %) |
| Mar 14 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | D | 60.73 | 2,834 | 172,111 | 115,252 | 118.1 K to 115.3 K (-2.40 %) |
| Mar 12 2018 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Grant | A | 0.00 | 38,502 | 39 | 118,086 | 79.6 K to 118.1 K (+48.38 %) |
| Dec 13 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 61.23 | 3,245 | 198,691 | 79,547 | 82.8 K to 79.5 K (-3.92 %) |
| Nov 30 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 60.00 | 6,490 | 389,400 | 82,792 | 89.3 K to 82.8 K (-7.27 %) |
| Sep 13 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | D | 71.81 | 3,347 | 240,359 | 89,282 | 92.6 K to 89.3 K (-3.61 %) |
| Sep 13 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | D | 71.81 | 4,184 | 300,467 | 92,629 | 96.8 K to 92.6 K (-4.32 %) |
| Sep 13 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 72.27 | 3,244 | 234,441 | 96,813 | 100.1 K to 96.8 K (-3.24 %) |
| Aug 11 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 71.18 | 3,244 | 230,921 | 99,989 | 103.2 K to 100 K (-3.14 %) |
| Jul 12 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Reg. Strategy, ... | Sell | S | 71.55 | 3,200 | 228,972 | 103,233 | 106.4 K to 103.2 K (-3.01 %) |
| Jun 13 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 69.06 | 3,200 | 220,989 | 106,433 | 109.6 K to 106.4 K (-2.92 %) |
| May 12 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 71.93 | 3,200 | 230,176 | 109,633 | 112.8 K to 109.6 K (-2.84 %) |
| Apr 12 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 78.19 | 3,200 | 250,208 | 112,833 | 116 K to 112.8 K (-2.76 %) |
| Mar 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 77.55 | 3,208 | 248,782 | 116,033 | 119.2 K to 116 K (-2.69 %) |
| Mar 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 77.55 | 6,694 | 519,124 | 119,241 | 125.9 K to 119.2 K (-5.32 %) |
| Mar 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 77.55 | 3,528 | 273,599 | 125,935 | 129.5 K to 125.9 K (-2.73 %) |
| Mar 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 77.71 | 3,200 | 248,672 | 129,463 | 132.7 K to 129.5 K (-2.41 %) |
| Mar 10 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Grant | A | 0.00 | 28,761 | 29 | 132,663 | 103.9 K to 132.7 K (+27.68 %) |
| Feb 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 9.80 | 727 | 7,125 | 0 | |
| Feb 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 79.30 | 2,473 | 196,109 | 103,872 | 106.3 K to 103.9 K (-2.33 %) |
| Feb 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 79.30 | 727 | 57,651 | 106,345 | 107.1 K to 106.3 K (-0.68 %) |
| Feb 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 9.80 | 727 | 7,125 | 107,072 | 106.3 K to 107.1 K (+0.68 %) |
| Jan 12 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 9.80 | 3,200 | 31,360 | 727 | |
| Jan 12 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 62.86 | 3,200 | 201,152 | 106,345 | 109.5 K to 106.3 K (-2.92 %) |
| Jan 12 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 9.80 | 3,200 | 31,360 | 109,545 | 106.3 K to 109.5 K (+3.01 %) |
| Oct 20 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 82.31 | 4,997 | 411,303 | 106,345 | 111.3 K to 106.3 K (-4.49 %) |
| Oct 07 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 82.55 | 5,000 | 412,750 | 111,342 | 116.3 K to 111.3 K (-4.30 %) |
| Sep 22 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 92.87 | 5,000 | 464,366 | 116,342 | 121.3 K to 116.3 K (-4.12 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 93.72 | 4,223 | 395,791 | 121,342 | 125.6 K to 121.3 K (-3.36 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 93.72 | 4,445 | 416,597 | 125,565 | 130 K to 125.6 K (-3.42 %) |
| Sep 09 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 4,999 | 15,947 | 0 | |
| Sep 09 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 94.45 | 4,999 | 472,156 | 130,010 | 135 K to 130 K (-3.70 %) |
| Sep 09 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 4,999 | 15,947 | 135,009 | 130 K to 135 K (+3.85 %) |
| Aug 26 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 5,000 | 15,950 | 4,999 | |
| Aug 26 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 91.72 | 5,000 | 458,600 | 129,979 | 135 K to 130 K (-3.70 %) |
| Aug 26 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 5,000 | 15,950 | 134,979 | 130 K to 135 K (+3.85 %) |
| Aug 12 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 5,000 | 15,950 | 9,999 | |
| Aug 12 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 90.26 | 5,000 | 451,300 | 129,979 | 135 K to 130 K (-3.70 %) |
| Aug 12 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 5,000 | 15,950 | 134,979 | 130 K to 135 K (+3.85 %) |
| Jul 28 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 5,000 | 15,950 | 14,999 | |
| Jul 28 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 88.14 | 5,000 | 440,700 | 129,979 | 135 K to 130 K (-3.70 %) |
| Jul 28 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 5,000 | 15,950 | 134,979 | 130 K to 135 K (+3.85 %) |
| Jul 14 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 5,000 | 15,950 | 19,999 | |
| Jul 14 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 80.12 | 5,000 | 400,600 | 129,979 | 135 K to 130 K (-3.70 %) |
| Jul 14 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 5,000 | 15,950 | 134,979 | 130 K to 135 K (+3.85 %) |
| Jul 01 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 5,000 | 15,950 | 24,999 | |
| Jul 01 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 78.10 | 5,000 | 390,500 | 129,979 | 135 K to 130 K (-3.70 %) |
| Jul 01 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 5,000 | 15,950 | 134,979 | 130 K to 135 K (+3.85 %) |
| Jun 20 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 3.19 | 55,000 | 175,450 | 29,999 | |
| Jun 20 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 75.00 | 55,000 | 4,125,000 | 129,979 | 185 K to 130 K (-29.73 %) |
| Jun 20 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 3.19 | 55,000 | 175,450 | 184,979 | 130 K to 185 K (+42.31 %) |
| Mar 15 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 63.96 | 4,430 | 283,348 | 129,979 | 134.4 K to 130 K (-3.30 %) |
| Mar 14 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 63.18 | 8,040 | 507,967 | 134,409 | 142.4 K to 134.4 K (-5.64 %) |
| Mar 14 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 63.18 | 3,328 | 210,263 | 142,449 | 145.8 K to 142.4 K (-2.28 %) |
| Mar 10 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Grant | A | 0.00 | 38,000 | 38 | 145,777 | 107.8 K to 145.8 K (+35.26 %) |
| Dec 21 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 3.19 | 7,500 | 23,925 | 84,999 | |
| Dec 21 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 82.52 | 7,500 | 618,869 | 107,680 | 115.2 K to 107.7 K (-6.51 %) |
| Dec 21 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 3.19 | 7,500 | 23,925 | 115,180 | 107.7 K to 115.2 K (+6.97 %) |
| Dec 04 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 3.19 | 7,500 | 23,925 | 92,499 | |
| Dec 04 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 86.37 | 7,500 | 647,781 | 107,680 | 115.2 K to 107.7 K (-6.51 %) |
| Dec 04 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 3.19 | 7,500 | 23,925 | 115,180 | 107.7 K to 115.2 K (+6.97 %) |
| Nov 30 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 3.19 | 7,500 | 23,925 | 99,999 | |
| Nov 30 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 87.49 | 7,500 | 656,192 | 107,680 | 115.2 K to 107.7 K (-6.51 %) |
| Nov 30 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 3.19 | 7,500 | 23,925 | 115,180 | 107.7 K to 115.2 K (+6.97 %) |
| Nov 24 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 3.19 | 4,800 | 15,312 | 107,499 | |
| Nov 24 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 3.19 | 5,200 | 16,588 | 112,299 | |
| Nov 24 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Gift | G | 0.00 | 5,477 | 0 | 107,680 | 113.2 K to 107.7 K (-4.84 %) |
| Nov 24 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 86.36 | 4,800 | 414,534 | 113,157 | 118 K to 113.2 K (-4.07 %) |
| Nov 24 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 3.19 | 4,800 | 15,312 | 117,957 | 113.2 K to 118 K (+4.24 %) |
| Nov 24 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 86.50 | 5,200 | 449,800 | 113,157 | 118.4 K to 113.2 K (-4.39 %) |
| Nov 24 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 3.19 | 5,200 | 16,588 | 118,357 | 113.2 K to 118.4 K (+4.60 %) |
| Nov 12 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 3.19 | 7,500 | 23,925 | 117,499 | |
| Nov 12 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 84.50 | 7,500 | 633,734 | 113,157 | 120.7 K to 113.2 K (-6.22 %) |
| Nov 12 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 3.19 | 7,500 | 23,925 | 120,657 | 113.2 K to 120.7 K (+6.63 %) |
| Oct 21 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 81.46 | 4,538 | 369,670 | 113,157 | 117.7 K to 113.2 K (-3.86 %) |
| Oct 07 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 82.29 | 8,216 | 676,083 | 117,695 | 125.9 K to 117.7 K (-6.53 %) |
| Sep 22 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 100.72 | 7,859 | 791,570 | 125,911 | 133.8 K to 125.9 K (-5.88 %) |